-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E/p4qKzc3F/IggF1iZwVdxD1DJSVOqgLpjGWCsRlsB1nnx2uJbFj4YzmG7ew7U0G GQwU2jl5myn4Emqedidvdg== 0001179110-06-002616.txt : 20060202 0001179110-06-002616.hdr.sgml : 20060202 20060202095839 ACCESSION NUMBER: 0001179110-06-002616 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060201 FILED AS OF DATE: 20060202 DATE AS OF CHANGE: 20060202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HARRIS ALAN G CENTRAL INDEX KEY: 0001351182 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 06571804 BUSINESS ADDRESS: BUSINESS PHONE: 212-582-9847 MAIL ADDRESS: STREET 1: 810 SEVENTH AVENUE 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125544555 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 edgar.xml FORM 4 - X0202 4 2006-02-01 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHA 0001351182 HARRIS ALAN G 810 SEVENTH AVENUE, 4TH FLOOR NEW YORK NY 10019 0 1 0 0 Chief Medical Officer Common Stock 0 D Stock Options 1.35 2006-02-01 4 A 0 300000 0 A 2016-02-01 Common Stock 300000 300000 D Option vests in increments of 100,000 each on 2/1/07, 2/1/08, and 2/1/09. /s/ Alan G. Harris 2006-02-02 -----END PRIVACY-ENHANCED MESSAGE-----